We are live on ! Find out more
MSS

Mitchell Sinkler & Starr Portfolio holdings

AUM $240M
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+2.46%
1 Year Est. Return
+24.63%
3 Year Est. Return
+72.22%
5 Year Est. Return
+87.27%
10 Year Est. Return
+266.58%
AUM
$221M
AUM Growth
-$1.08M
Cap. Flow
-$4.39M
Cap. Flow %
-1.99%
Top 10 Hldgs %
38.08%
Holding
145
New
3
Increased
27
Reduced
62
Closed
6

Top Sells

Rank Stock Value
1
VTI icon
Vanguard Total Stock Market ETF
VTI
+$1.25M
2
NVDA icon
NVIDIA
NVDA
+$485K
3
UNH icon
UnitedHealth
UNH
+$472K
4
DHI icon
D.R. Horton
DHI
+$426K
5
ADBE icon
Adobe
ADBE
+$365K

Sector Composition

Rank Sector Weight
1 Technology 22.9%
2 Healthcare 11.09%
3 Financials 8.02%
4 Consumer Staples 7.41%
5 Industrials 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.84T
$12.5M 5.65%
25,867
+105
+0.4% +$52.6K
AAPL icon
2
Apple
AAPL
$4.89T
$12.3M 5.54%
45,102
-80
-0.2% -$21.5K
NVDA icon
3
NVIDIA
NVDA
$5.01T
$10.7M 4.81%
57,107
-2,604
-4% -$485K
VOO icon
4
Vanguard S&P 500 ETF
VOO
$968B
$10.1M 4.57%
16,123
+1,336
+9% +$830K
SCHB icon
5
Schwab US Broad Market ETF
SCHB
$42.8B
$8.59M 3.88%
327,595
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$3.91T
$7.77M 3.51%
24,810
-279
-1% -$79.7K
PG icon
7
Procter & Gamble
PG
$343B
$7.62M 3.44%
53,188
-459
-0.9% -$67.7K
VTI icon
8
Vanguard Total Stock Market ETF
VTI
$654B
$5.83M 2.63%
17,395
-3,755
-18% -$1.25M
JNJ icon
9
Johnson & Johnson
JNJ
$634B
$4.48M 2.02%
21,647
-219
-1% -$43.3K
MRK icon
10
Merck
MRK
$324B
$4.45M 2.01%
42,297
-2,480
-6% -$233K
AMZN icon
11
Amazon
AMZN
$2.5T
$3.91M 1.77%
16,939
-100
-0.6% -$22.9K
SPY icon
12
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$3.73M 1.68%
5,465
-30
-0.5% -$20.3K
JPM icon
13
JPMorgan Chase
JPM
$939B
$3.67M 1.66%
11,389
-120
-1% -$37.2K
IWB icon
14
iShares Russell 1000 ETF
IWB
$47.7B
$3.62M 1.64%
9,700
+50
+0.5% +$18.5K
VGT icon
15
Vanguard Information Technology ETF
VGT
$139B
$3.23M 1.46%
34,304
+600
+2% +$57K
HD icon
16
Home Depot
HD
$332B
$3.2M 1.45%
9,305
-135
-1% -$49.4K
ABBV icon
17
AbbVie
ABBV
$458B
$3.14M 1.42%
13,727
+230
+2% +$52.4K
MA icon
18
Mastercard
MA
$477B
$3.05M 1.38%
5,347
-101
-2% -$56.5K
META icon
19
Meta Platforms (Facebook)
META
$1.51T
$3.05M 1.38%
4,616
+299
+7% +$200K
ADP icon
20
Automatic Data Processing
ADP
$100B
$3.04M 1.37%
11,826
-265
-2% -$70.5K
RTX icon
21
RTX Corp
RTX
$287B
$3.04M 1.37%
16,583
-1,216
-7% -$211K
ABT icon
22
Abbott
ABT
$180B
$2.78M 1.26%
22,215
-180
-0.8% -$22.9K
XOM icon
23
ExxonMobil
XOM
$651B
$2.57M 1.16%
21,366
+1,710
+9% +$198K
PEP icon
24
PepsiCo
PEP
$186B
$2.49M 1.13%
17,362
-725
-4% -$107K
SCHD icon
25
Schwab US Dividend Equity ETF
SCHD
$102B
$2.46M 1.11%
89,807
-1,900
-2% -$51.7K

Similar funds

Mitchell Sinkler & Starr's Q4 2025 Portfolio in Review

As of Q4 2025, Mitchell Sinkler & Starr held 145 positions worth $221M, down 0.49% from $222M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Mitchell Sinkler & Starr's Q4 2025 filing shows 3 new, 27 increased, 62 reduced and 6 closed positions. Its largest new stake was TD Synnex: 1,848 shares worth $278K. The largest sale was Vanguard Total Stock Market ETF, an estimated $1.25M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Mitchell Sinkler & Starr's largest Q4 2025 buy was TD Synnex: 1,848 shares worth $278K.
  • Mitchell Sinkler & Starr added most to Vanguard S&P 500 ETF in Q4 2025, an estimated $830K increase.
  • Mitchell Sinkler & Starr's biggest Q4 2025 reduction was Vanguard Total Stock Market ETF, cutting an estimated $1.25M.
  • Mitchell Sinkler & Starr fully exited UnitedHealth in Q4 2025, selling an estimated $472K.
  • Mitchell Sinkler & Starr's ten largest holdings make up 38% of its $221M portfolio in Q4 2025.
  • Mitchell Sinkler & Starr opened 3 new positions and closed 6 in Q4 2025.
  • Mitchell Sinkler & Starr's portfolio value fell 0.49% quarter-over-quarter to $221M.

Based on Mitchell Sinkler & Starr's 13F filing for Q4 2025, filed 11 Feb 2026.